Works matching IS 1007385X AND DT 2024 AND VI 31 AND IP 3

Results: 15

骨肉瘤抗血管生成靶向治疗的研究进展.

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 3, p. 303, doi. 10.3872/j.issn.1007-385x.2024.03.014

By:

陈倩倩;
蔡小攀

Publication type:

Article

细菌介导的肿瘤协同治疗策略.

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 3, p. 296, doi. 10.3872/j.issn.1007-385x.2024.03.013

By:

任昊喆;
杨铁虹;
王静

Publication type:

Article

复合原位疫苗模式用于双免疫治疗后仍进展的胸膜间皮瘤1 例报告及文献复习

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 3, p. 310, doi. 10.3872/j.issn.1007-385x.2024.03.015

By:

戴娟娟;
王晓露;
杜诗尧;
闵丽梅;
齐浩月;
卞丽娟;
吕佳;
陈诗卉;
周霞;
刘娟;
刘宝瑞;
李茹恬

Publication type:

Article

糖代谢重编程在卵巢癌化疗耐药中作用的研究进展.

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 3, p. 289, doi. 10.3872/j.issn.1007-385x.2024.03.012

By:

周露;
阳志军

Publication type:

Article

新型免疫检查点分子VISTA的研究进展.

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 3, p. 283, doi. 10.3872/j.issn.1007-385x.2024.03.011

By:

吴昊宇;
蒋敬庭

Publication type:

Article

γδT细胞识别机制研究进展.

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 3, p. 277, doi. 10.3872/j.issn.1007-385x.2024.03.010

By:

陈怡宁;
唐玲;
于益芝

Publication type:

Article

基于真实世界数据分析中医药非介入治疗肺恶性肿瘤的辨治规律.

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 3, p. 271, doi. 10.3872/j.issn.1007-385x.2024.03.009

By:

卢思玮;
程淼

Publication type:

Article

基于GINS家族成员在胶质瘤组织中的表达水平对其进行分型及其临床意义.

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 3, p. 261, doi. 10.3872/j.issn.1007-385x.2024.03.008

By:

廖永珍;
梁禄;
李意;
丛丽

Publication type:

Article

2023 年γδT细胞肿瘤治疗领域重大进展.

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 3, p. 211, doi. 10.3872/j.issn.1007-385x.2024.03.001

By:

赵跃祺;
张建民;
陈慧;
何维

Publication type:

Article

同种异体γδT细胞免疫疗法治疗晚期肝细胞癌的安全性及其对患者免疫功能的影响

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 3, p. 253, doi. 10.3872/j.issn.1007-385x.2024.03.007

By:

陈彦;
张亦甜;
徐艳;
李曼;
黎嘉伟;
孟令雯;
向征;
刘冰;
尹芝南;
吴斌

Publication type:

Article

茯苓酸通过调控AKT/MDM2/p53 通路影响结直肠癌HCT116 细胞的恶性生物学行为.

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 3, p. 247, doi. 10.3872/j.issn.1007-385x.2024.03.006

By:

张美华;
赵文睫;
李康;
曲巧燕;
郝建波

Publication type:

Article

雷公藤内酯醇通过调控miR-142-3p/HSP70 通路抑制人乳腺癌MCF-7 细胞增殖、侵袭和迁移.

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 3, p. 240, doi. 10.3872/j.issn.1007-385x.2024.03.005

By:

王进军;
崔鹏来;
程欣;
钱梦悦;
曾祥隽;
徐子金;
王怡帆

Publication type:

Article

miR-3612 靶向SEMA4C调控肝细胞癌细胞的恶性生物学行为.

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 3, p. 231, doi. 10.3872/j.issn.1007-385x.2024.03.004

By:

马思源;
张博超;
李贤锐;
程新悦;
浦春

Publication type:

Article

虎杖苷通过Hippo/YAP通路影响甲状腺癌8505C细胞的恶性生物学行为和顺铂敏感性.

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 3, p. 224, doi. 10.3872/j.issn.1007-385x.2024.03.003

By:

曹建中;
黄金石;
丁亚亭

Publication type:

Article

白藜芦醇通过下调PRMT5表达抑制肝胆管癌SMMC-7721细胞的增殖、侵袭和细胞周期.

Published in:

Chinese Journal of Cancer Biotherapy, 2024, v. 31, n. 3, p. 219, doi. 10.3872/j.issn.1007-385x.2024.03.002

By:

沈兴艳;
孙象军

Publication type:

Article